Lonza enters development and manufacturing agreement with Genmab A/S for a novel antibody drug conjugate (ADC), HuMax-TF™
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.finanznachrichten.de/pdf/20111025_190537_O6Z_72DE113FD45B00AF482579340035DF7E.1.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
